The Stockholm3 model combines PSA, plasma protein biomarkers, polygenic risk, and clinical factors for prostate cancer screening.
The Queen Zone on MSN
New blood test could help spot aggressive prostate cancer earlier
For many men, a prostate cancer scare starts with one number. A PSA result comes back high, and ...
(HealthDay News) — Stockholm3, which combines prostate-specific antigen (PSA), plasma protein biomarkers, polygenic risk, and clinical factors offers greater clinical net benefit for detecting ...
A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...
Hosted on MSN
New prostate cancer test detects more dangerous tumours than standard PSA screening, study finds
Researchers in Sweden say a tool, known as Stockholm3, finds 90 per cent of 'clinically significant' prostate cancers, compared with 74 per cent uncovered by the standard prostate-specific antigen ...
Annals of Internal Medicine publishes study showing potential benefits of Stockholm3 in identifying patients with aggressive prostate cancerSTOCKHOLM, June 22, 2026 (GLOBE NEWSWIRE) -- A3P Biomedical, ...
(Aging Untold) — Prostate cancer is one of the most common cancers for men in the United States, but deciding when to get screened isn’t always clear. While a PSA blood test can help find prostate ...
Fear of discomfort and unnecessary treatment often deters patients from prostate cancer screening, despite the benefits of early detection. Prostate cancer can be asymptomatic, making early detection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results